Ann: Quarterly Report and Appendix 4C, page-58

Definitely I'm not a science expert, I'm just an ordinary investor.

Here's the info:

Antisense drugs focus on the RNA “messengers”, thus tackling a much wider array of targets. While the effect is the same — the protein production is inhibited — there are key advantages.

In the company’s words: “Antisense drugs don’t require the complex and time-consuming analysis of the structure of the target protein that is required for conventional (small molecule) drugs.”

Once the company has identified a therapeutic application and corresponding gene target, an antisense inhibitor compound can be designed within hours suitable for use in research and clinical trials.